
-
Glasner says demotion to Conference League would punish 'innocent' Palace
-
New Zealand build big total in 2nd Test against Zimbabwe
-
Trump hosts foes Armenia, Azerbaijan in his latest peace initiative
-
Nigerian scientists await return of Egusi seeds sent to space
-
Pioneer spirit drives Swiss solar-powered plane altitude attempt
-
Thyssenkrupp to spin off marine division amid defence boom
-
Vance and Lammy talk Gaza, fish as US VP starts UK holiday
-
Israel plans to 'take control' of Gaza City, sparking wave of criticism
-
Putin taps key allies ahead of Trump summit, sanctions deadline
-
Two tourists die, fires erupt in Greece amid gale-force winds
-
Lens sign France international Thauvin from Udinese
-
Gold futures hit record on US tariff shock, stocks wobble
-
Man Utd training ground upgrade will foster 'winning culture': Ratcliffe
-
Two tourists die at sea in Greece amid gale-force winds
-
'Optimistic': Champagne growers hope for US tariff shift
-
French firefighters optimistic after controlling vast wildfire
-
Germany suspends arms exports to Israel for use in Gaza
-
Stocks waver, gold futures hit record on US tariff updates
-
Guessand says he jumped at chance to join Aston Villa after sealing move
-
Israel to 'take control' of Gaza City, sparking wave of criticism
-
Accumulating bitcoin a risky digital rush by companies?
-
Liverpool's Slot hints at fresh Isak bid despite 'attacking power'
-
PSG to sign Lille goalkeeper Lucas Chevalier: source
-
Oil industry presence surges at UN plastic talks: NGOs
-
Kipyegon says a woman will run a sub-four minute mile
-
Tokyo soars on trade deal relief as most Asian markets limp into weekend
-
Israel to 'take control' of Gaza City after approving new war plan
-
Australian A-League side Western United stripped of licence
-
'Back home': family who fled front buried after Kyiv strike
-
Indonesia cracks down on pirate protest flag
-
Israeli army will 'take control' of Gaza City: PM's office
-
Australian mushroom murderer accused of poisoning husband
-
Coventry's mettle tested by Russian Olympic debate, say former IOC figures
-
Library user borrows rare Chinese artwork, returns fakes: US officials
-
Parisians hot under the collar over A/C in apartments
-
Crypto group reportedly says it planned sex toy tosses at WNBA games
-
American Shelton tops Khachanov to win first ATP Masters title in Toronto
-
Tokyo soars on trade deal relief as Asian markets limp into weekend
-
New species teem in Cambodia's threatened karst
-
Australian mushroom murderer accused of poisoning husband: police
-
Solid gold, royal missives and Nobel noms: how to win Trump over
-
Canadian teen Mboko outlasts Osaka to win WTA Montreal crown
-
Trump to host Armenia, Azerbaijan for historic 'Peace Signing'
-
Israeli airline's Paris offices daubed with red paint, slogans
-
US raises bounty on Venezuela's Maduro to $50 mn
-
Lebanon cabinet meets again on Hezbollah disarmament
-
France's huge wildfire will burn for days: authorities
-
Bolivia right-wing presidential hopeful vows 'radical change'
-
Trump says would meet Putin without Zelensky sit-down
-
Trump offers data to justify firing of labor stats chief
RBGPF | -5.79% | 71.84 | $ | |
RYCEF | 0.07% | 14.46 | $ | |
CMSC | 0.43% | 23.06 | $ | |
VOD | 1.01% | 11.375 | $ | |
BCC | -0.2% | 83.02 | $ | |
GSK | 0.83% | 37.895 | $ | |
RIO | 1.92% | 61.96 | $ | |
AZN | -0.76% | 73.495 | $ | |
SCS | 0.06% | 16.01 | $ | |
SCU | 0% | 12.72 | $ | |
JRI | -0.04% | 13.405 | $ | |
NGG | -1.04% | 71.335 | $ | |
RELX | -1.76% | 48.21 | $ | |
CMSD | -0.13% | 23.49 | $ | |
BTI | 0.6% | 57.035 | $ | |
BCE | 2.52% | 24.395 | $ | |
BP | 0.06% | 34.21 | $ |

Moderna rebuked over plan to hike Covid vaccine to $130
Moderna's chief executive on Wednesday defended the US company's plan to quadruple the price of its lifesaving Covid vaccine to as much as $130 per dose as soon as government stockpiles run out.
Democratic Senator Bernie Sanders lashed out at the price hike, denouncing the "unprecedented level of corporate greed" in the pharmaceutical industry. "And that is certainly true with Moderna," Sanders said.
Moderna has so far charged between about $15 and $26 for doses of its vaccine, according to the Kaiser Family Foundation.
The US government subsidized $1.7 billion of Moderna's research at the start of the pandemic and then purchased $10 billion worth of vaccine, Sanders said at a Senate hearing where the company's CEO Stephane Bancel was testifying.
Sanders said Moderna was "thanking the taxpayers of the United States" by more than quadrupling the vaccine's price "at a time when it costs less than $3 to manufacture."
Sanders noted several times at the hearing that Moderna conducted buybacks of its own stock and paid its own executives at its Cambridge, Massachusetts, headquarters handsomely.
Bancel defended Moderna, saying the distribution system will change completely when the US government lifts a state of health emergency, perhaps as soon as May.
Up until now, Moderna had only one customer, distributed its vaccine to only a few warehouses and did not have to pay for the cost of expired doses.
By switching to a more traditional marketing approach, "we're going to have 10,000 customers" and have to "manage to deliver to 60,000 pharmacies, doctors' offices and hospitals," he added.
Currently distributed in multidose vials, the vaccine will be sold mostly in single-dose vials or directly in prefilled syringes. And Moderna will have to take care of the unsold doses.
The company expects a "90 percent reduction in demand," Bancel said. "We are losing economies of scale. We must assume the wastage risk and cost that the US government used to assume."
Moderna also pledged to set up a program so that the uninsured or underinsured would not have to pay anything.
When pressed by Sanders about the possibility of the company lowering its price for government-run health insurance programs, Bancel said discussions were underway with all customers.
V.AbuAwwad--SF-PST